Burden Sorrel, Jones Debra J, Sremanakova Jana, Sowerbutts Anne Marie, Lal Simon, Pilling Mark, Todd Chris
The University of Manchester, and Manchester Academic Health Science Centre, School of Health Sciences, Manchester, UK, M13 9PL.
Salford Royal Foundation Trust, Intestinal Failure Unit, Salford, UK, M6 8HD.
Cochrane Database Syst Rev. 2019 Nov 22;2019(11):CD011287. doi: 10.1002/14651858.CD011287.pub2.
International dietary recommendations include guidance on healthy eating and weight management for people who have survived cancer; however dietary interventions are not provided routinely for people living beyond cancer.
To assess the effects of dietary interventions for adult cancer survivors on morbidity and mortality, changes in dietary behaviour, body composition, health-related quality of life, and clinical measurements.
We ran searches on 18 September 2019 and searched the Cochrane Central Register of Controlled trials (CENTRAL), in the Cochrane Library; MEDLINE via Ovid; Embase via Ovid; the Allied and Complementary Medicine Database (AMED); the Cumulative Index to Nursing and Allied Health Literature (CINAHL); and the Database of Abstracts of Reviews of Effects (DARE). We searched other resources including reference lists of retrieved articles, other reviews on the topic, the International Trials Registry for ongoing trials, metaRegister, Physicians Data Query, and appropriate websites for ongoing trials. We searched conference abstracts and WorldCat for dissertations.
We included randomised controlled trials (RCTs) that recruited people following a cancer diagnosis. The intervention was any dietary advice provided by any method including group sessions, telephone instruction, written materials, or a web-based approach. We included comparisons that could be usual care or written information, and outcomes measured included overall survival, morbidities, secondary malignancies, dietary changes, anthropometry, quality of life (QoL), and biochemistry.
We used standard Cochrane methodological procedures. Two people independently assessed titles and full-text articles, extracted data, and assessed risk of bias. For analysis, we used a random-effects statistical model for all meta-analyses, and the GRADE approach to rate the certainty of evidence, considering limitations, indirectness, inconsistencies, imprecision, and bias.
We included 25 RCTs involving 7259 participants including 977 (13.5%) men and 6282 (86.5%) women. Mean age reported ranged from 52.6 to 71 years, and range of age of included participants was 23 to 85 years. The trials reported 27 comparisons and included participants who had survived breast cancer (17 trials), colorectal cancer (2 trials), gynaecological cancer (1 trial), and cancer at mixed sites (5 trials). For overall survival, dietary intervention and control groups showed little or no difference in risk of mortality (hazard ratio (HR) 0.98, 95% confidence interval (CI) 0.77 to 1.23; 1 study; 3107 participants; low-certainty evidence). For secondary malignancies, dietary interventions versus control trials reported little or no difference (risk ratio (RR) 0.99, 95% CI 0.84 to 1.15; 1 study; 3107 participants; low-certainty evidence). Co-morbidities were not measured in any included trials. Subsequent outcomes reported after 12 months found that dietary interventions versus control probably make little or no difference in energy intake at 12 months (mean difference (MD) -59.13 kcal, 95% CI -159.05 to 37.79; 5 studies; 3283 participants; moderate-certainty evidence). Dietary interventions versus control probably led to slight increases in fruit and vegetable servings (MD 0.41 servings, 95% CI 0.10 to 0.71; 5 studies; 834 participants; moderate-certainty evidence); mixed results for fibre intake overall (MD 5.12 g, 95% CI 0.66 to 10.9; 2 studies; 3127 participants; very low-certainty evidence); and likely improvement in Diet Quality Index (MD 3.46, 95% CI 1.54 to 5.38; 747 participants; moderate-certainty evidence). For anthropometry, dietary intervention versus control probably led to a slightly decreased body mass index (BMI) (MD -0.79 kg/m², 95% CI -1.50 to -0.07; 4 studies; 777 participants; moderate-certainty evidence). Dietary interventions versus control probably had little or no effect on waist-to-hip ratio (MD -0.01, 95% CI -0.04 to 0.02; 2 studies; 106 participants; low-certainty evidence). For QoL, there were mixed results; several different quality assessment tools were used and evidence was of low to very low-certainty. No adverse events were reported in any of the included studies.
AUTHORS' CONCLUSIONS: Evidence demonstrated little effects of dietary interventions on overall mortality and secondary cancers. For comorbidities, no evidence was identified. For nutritional outcomes, there was probably little or no effect on energy intake, although probably a slight increase in fruit and vegetable intake and Diet Quality Index. Results were mixed for fibre. For anthropometry, there was probably a slight decrease in body mass index (BMI) but probably little or no effect on waist-to-hip ratio. For QoL, results were highly varied. Additional high-quality research is needed to examine the effects of dietary interventions for different cancer sites, and to evaluate important outcomes including comorbidities and body composition. Evidence on new technologies used to deliver dietary interventions was limited.
国际饮食建议为癌症幸存者提供了关于健康饮食和体重管理的指导;然而,对于癌症康复者,饮食干预并未常规提供。
评估成人癌症幸存者饮食干预对发病率和死亡率、饮食行为变化、身体成分、健康相关生活质量及临床指标的影响。
我们于2019年9月18日进行检索,检索了Cochrane图书馆中的Cochrane系统评价数据库(CENTRAL);通过Ovid检索MEDLINE;通过Ovid检索Embase;检索联合与补充医学数据库(AMED);护理及相关健康文献累积索引(CINAHL);以及效果评价文摘数据库(DARE)。我们还检索了其他资源,包括检索到文章的参考文献列表、关于该主题的其他综述、正在进行试验的国际试验注册库、metaRegister、医师数据查询以及正在进行试验的相关网站。我们检索了会议摘要和WorldCat中的学位论文。
我们纳入了招募癌症诊断后人群的随机对照试验(RCT)。干预措施为通过任何方法提供的饮食建议,包括小组课程、电话指导、书面材料或基于网络的方法。我们纳入的对照可以是常规护理或书面信息,测量的结局包括总生存期、发病率、二次恶性肿瘤、饮食变化、人体测量学指标、生活质量(QoL)和生物化学指标。
我们采用标准的Cochrane方法学程序。两人独立评估标题和全文文章,提取数据并评估偏倚风险。对于分析,我们对所有荟萃分析使用随机效应统计模型,并采用GRADE方法对证据的确定性进行分级,考虑局限性、间接性、不一致性、不精确性和偏倚。
我们纳入了25项RCT,涉及7259名参与者,其中男性977名(13.5%),女性6282名(86.5%)。报告的平均年龄范围为52.6至71岁,纳入参与者的年龄范围为23至85岁。这些试验报告了27项比较,纳入的参与者包括乳腺癌幸存者(17项试验)、结直肠癌幸存者(2项试验)、妇科癌症幸存者(1项试验)以及混合部位癌症幸存者(5项试验)。对于总生存期,饮食干预组和对照组在死亡风险方面几乎没有差异(风险比(HR)0.98,95%置信区间(CI)0.77至1.23;1项研究;3107名参与者;低确定性证据)。对于二次恶性肿瘤,饮食干预试验与对照试验报告几乎没有差异(风险比(RR)0.99,95%CI 0.84至1.15;1项研究;3107名参与者;低确定性证据)。纳入的任何试验均未测量合并症。12个月后报告的后续结局发现,饮食干预与对照相比,12个月时能量摄入可能几乎没有差异(平均差(MD)-59.13千卡,95%CI -159.05至37.79;5项研究;3283名参与者;中等确定性证据)。饮食干预与对照相比可能导致水果和蔬菜摄入量略有增加(MD 0.41份,95%CI 0.10至0.71;5项研究;834名参与者;中等确定性证据);纤维摄入量总体结果不一(MD 5.12克,95%CI 0.66至10.9;2项研究;3127名参与者;极低确定性证据);饮食质量指数可能有所改善(MD 3.46,95%CI 1.54至5.38;747名参与者;中等确定性证据)。对于人体测量学指标,饮食干预与对照相比可能导致体重指数(BMI)略有下降(MD -0.79kg/m²,95%CI -1.50至-0.07;4项研究;777名参与者;中等确定性证据)。饮食干预与对照相比对腰臀比可能几乎没有影响(MD -0.01,95%CI -0.04至0.02;2项研究;106名参与者;低确定性证据)。对于生活质量,结果不一;使用了几种不同的质量评估工具,证据的确定性为低到极低。纳入的任何研究均未报告不良事件。
证据表明饮食干预对总死亡率和二次癌症几乎没有影响。对于合并症,未发现相关证据。对于营养结局,对能量摄入可能几乎没有影响,尽管水果和蔬菜摄入量及饮食质量指数可能略有增加。纤维方面结果不一。对于人体测量学指标,体重指数(BMI)可能略有下降,但对腰臀比可能几乎没有影响。对于生活质量,结果差异很大。需要更多高质量研究来考察不同癌症部位饮食干预的效果,并评估包括合并症和身体成分在内的重要结局。关于用于提供饮食干预的新技术的证据有限。